4.7 Article

Mortality Attributable to Bloodstream Infections Caused by Different Carbapenem-Resistant Gram-Negative Bacilli: Results From a Nationwide Study in Italy (ALARICO Network)

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Infectious Diseases

European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine)

Mical Paul et al.

Summary: These guidelines address the targeted antibiotic treatment of 3GCephRE and carbapenem-resistant Gram-negative bacteria, focusing on the effectiveness of individual antibiotics and on combination versus monotherapy. Most recommendations are based on low-certainty evidence.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Article Medicine, General & Internal

Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis

Christopher J. L. Murray et al.

Summary: Antimicrobial resistance (AMR) poses a significant threat to global human health, and this study provides the most comprehensive estimates of AMR burden to date. By estimating deaths and disability-adjusted life-years (DALYs) associated with bacterial AMR in 204 countries and territories in 2019, the study highlights the impact of resistance and the leading pathogen-drug combinations contributing to it.

LANCET (2022)

Article Infectious Diseases

Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study)

Marco Falcone et al.

Summary: The study found that NDM-Kp is associated with a higher risk of BSI compared to KPC-Kp, and this association seems to be strongly related to the high-risk clone ST147.

CLINICAL MICROBIOLOGY AND INFECTION (2022)

Article Microbiology

Cefiderocol- Compared to Colistin-Based Regimens for the Treatment of Severe Infections Caused by Carbapenem-Resistant Acinetobacter baumannii

Marco Falcone et al.

Summary: Cefiderocol appears to be a promising therapeutic option for carbapenem-resistant Acinetobacter baumannii (CRAB) infections, with a potential protective effect on 30-day mortality. However, further studies are needed to address the issue of microbiological failure.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2022)

Article Immunology

Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Pranita D. Tamma et al.

Summary: This article provides updated guidance on the treatment of infections caused by ESBL-E, CRE, and DTR-P. aeruginosa. The guidance was developed by a panel of infectious diseases specialists and includes preferred and alternative treatment recommendations. The document emphasizes the importance of consulting with an infectious diseases specialist for the treatment of antimicrobial-resistant infections.

CLINICAL INFECTIOUS DISEASES (2022)

Review Infectious Diseases

Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM)

Giusy Tiseo et al.

Summary: The management of infections caused by multidrug-resistant organisms is challenging and requires a multidisciplinary approach. This paper provides recommendations for the diagnosis and optimal management of these infections, with a focus on targeted antibiotic therapy. However, the available evidence is limited, and some recommendations are based on low certainty. These recommendations should be regularly updated.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)

Review Infectious Diseases

Diagnosis and management of infections caused by multidrug-resistant bacteria: guideline endorsed by the Italian Society of Infection and Tropical Diseases (SIMIT), the Italian Society of Anti-Infective Therapy (SITA), the Italian Group for Antimicrobial Stewardship (GISA), the Italian Association of Clinical Microbiologists (AMCLI) and the Italian Society of Microbiology (SIM)

Giusy Tiseo et al.

Summary: Managing infections caused by multidrug-resistant organisms requires a multidisciplinary approach, with a focus on targeted antibiotic therapy. Recommendations were developed by experts nominated by Italian societies, with classifications based on the certainty of evidence, although some recommendations have low certainty due to limited clinical trial data.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2022)

Article Immunology

Efficacy of Ceftazidime-avibactam Plus Aztreonam in Patients With Bloodstream Infections Caused by Metallo-β-lactamase-Producing Enterobacterales

Marco Falcone et al.

Summary: This study aimed to compare the outcomes of patients with MBL-producing Enterobacterales bloodstream infections treated with CAZ-AVI + ATM or other active antibiotics. The results showed that CAZ-AVI + ATM was associated with lower 30-day mortality, lower clinical failure at day 14, and shorter length of stay.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

Cefiderocol as Rescue Therapy for Acinetobacter baumannii and Other Carbapenem-resistant Gram-negative Infections in Intensive Care Unit Patients

Marco Falcone et al.

Summary: In this study, cefiderocol was used to treat patients with bacteremia or ventilator-associated pneumonia caused by drug-resistant strains, showing a 70% clinical success rate and 90% survival rate. However, two patients experienced microbiological failure, highlighting the need for future prospective studies to further evaluate the effectiveness of the treatment.

CLINICAL INFECTIOUS DISEASES (2021)

Review Medicine, General & Internal

Impact of carbapenem resistance on mortality in patients infected with Enterobacteriaceae: a systematic review and meta-analysis

Ruyin Zhou et al.

Summary: The study found that carbapenem resistance has a significant positive effect on the probability of death for patients infected with Enterobacteriaceae. Stratified analysis and meta-regression results suggested that the effect of carbapenem resistance on the risk of death varies by infection type, sample size, and year of publication.

BMJ OPEN (2021)

Article Microbiology

Epidemiology of Carbapenem Resistance Determinants Identified in Meropenem-Nonsusceptible Enterobacterales Collected as Part of a Global Surveillance Program, 2012 to 2017

Krystyna M. Kazmierczak et al.

Summary: The study estimated the incidence of carbapenem-resistant Enterobacterales globally and found that the resistance mechanisms varied by region, with KPC-type, metallo-beta-lactamases, and OXA-48-like beta-lactamases being the main contributors. The overall percentage of meropenem-nonsusceptible Enterobacterales increased from 2012 to 2017, with different carbapenemase types showing increasing proportions in different regions.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Immunology

Regional Spread of blaNDM-1-Containing Klebsiella pneumoniae ST147 in Post-Acute Care Facilities

Zena Lapp et al.

Summary: The study identified a regional outbreak of bla(NDM-1) ST147 in post-acute care facilities in the Chicago area, which was due to the clonal dissemination of the strains between specific facilities. Genomic analysis through whole-genome sequencing revealed the clonal spread and evolutionary process of these CRE strains.

CLINICAL INFECTIOUS DISEASES (2021)

Article Immunology

New Delhi Metallo-β-Lactamase-Producing Enterobacterales Bacteria, Switzerland, 2019-2020

Jacqueline Findlay et al.

Summary: The study in Switzerland found that NDM-positive CPE, primarily consisting of Klebsiella pneumoniae and Escherichia coli, were prevalent, with NDM-1 and NDM-5 variants being the most common. Some isolates also co-produced a second carbapenemase and a 16S rRNA methylase. Successful plasmids and global lineages were identified as major factors contributing to the increasing prevalence of NDMs in Switzerland.

EMERGING INFECTIOUS DISEASES (2021)

Editorial Material Immunology

Resilience of the Pitt Bacteremia Score: 3 Decades and Counting

Majdi N. Al-Hasan et al.

CLINICAL INFECTIOUS DISEASES (2020)

Review Microbiology

Epidemiology of beta-Lactamase-Producing Pathogens

Karen Bush et al.

CLINICAL MICROBIOLOGY REVIEWS (2020)

Review Infectious Diseases

Quantification and interpretation of attributable mortality in core clinical infectious disease journals

Maja von Cube et al.

LANCET INFECTIOUS DISEASES (2020)

Editorial Material Public, Environmental & Occupational Health

The C-Word: Scientific Euphemisms Do Not Improve Causal Inference From Observational Data

Miguel A. Hernan

AMERICAN JOURNAL OF PUBLIC HEALTH (2018)

Article Infectious Diseases

The GISA call to action for the appropriate use of antimicrobials and the control of antimicrobial resistance in Italy

Francesco Menichetti et al.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2018)

Article Immunology

Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections

Matthew E. Falagas et al.

EMERGING INFECTIOUS DISEASES (2014)

Article Computer Science, Interdisciplinary Applications

Adjusted survival curves with inverse probability weights

SR Cole et al.

COMPUTER METHODS AND PROGRAMS IN BIOMEDICINE (2004)

Review Public, Environmental & Occupational Health

Guidelines for the prevention of intravascular catheter-related infections

NP O'Grady et al.

AMERICAN JOURNAL OF INFECTION CONTROL (2002)